Showing results (471-480 of 488) with videos related to

Sort By:
Pageof 49
Neurology|August 22, 2022
Novelty-Related fMRI Responses of Precuneus and Medial Temporal Regions in Individuals at Risk for Alzheimer DiseaseOrnella V Billette, Gabriel Ziegler, Merita Aruci, et al.
Alzheimer'S Research & Therapy|March 1, 2023
Brain reserve contributes to distinguishing preclinical Alzheimer's stages 1 and 2Zerrin Yildirim, Firuze Delen, David Berron, et al.
Scientific Reports|November 12, 2025
An unsupervised XAI framework for dementia detection with context enrichmentDevesh Singh, Yusuf Brima, Fedor Levin, et al.
Journal of Alzheimer'S Disease : JAD|February 22, 2023
A Residual Marker of Cognitive Reserve Is Associated with Resting-State Intrinsic Functional Connectivity Along the Alzheimer's Disease ContinuumErsin Ersoezlue, Robert Perneczky, Maia Tato, et al.
Nature Communications|July 4, 2026
Joint trajectories of brain atrophy, white matter hyperintensities and cognition quantify brain maintenanceInga Menze, Jose Bernal, Rogier A Kievit, et al.
Neurobiology of Aging|December 8, 2022
Lifelong experiences as a proxy of cognitive reserve moderate the association between connectivity and cognition in Alzheimer's diseaseErsin Ersoezlue, Boris-Stephan Rauchmann, Thomas Schneider-Axmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 18, 2023
Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohortsXueyan Jiang, Xiaochen Hu, Marcel Daamen, et al.
Neurology|January 27, 2026
Patterns and Trajectories of Behavioral and Neuropsychiatric Symptoms in Frontotemporal Dementia and Primary Progressive AphasiaLena Marth, Francisco J Martinez-Murcia, Juan-Manuel Górriz-Sáez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2025
Disease stage-specific atrophy markers in Alzheimer's diseaseHannah Baumeister, Helena M Gellersen, Sarah E Polk, et al.
Alzheimer'S Research & Therapy|January 11, 2023
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE studyFrederic Brosseron, Anne Maass, Luca Kleineidam, et al.
Pageof 49